HopeStage
Back to all studies
WithdrawnNCT01557933

Effects of Electroconvulsive Therapy (ECT) in Depression in bipolarity

Observational studyAges 18–55
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2011
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Mclean Hospital
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Other
Locations
Not clearly listed
Age range
From 18 Years to 55 Years
Official registry ID
NCT01557933
Official title
Show the full official title

A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression

Recruitment & locations

Withdrawn

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Mclean Hospital, a hospital or academic medical center.

Who can participate?

This study is for people with bipolarity. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies